Burt Adelman. Novo Ventures
Here's a $25M seed fund aimed at backing some brash new drug ideas out of the Broad
As a former academic and a seasoned drug developer, Burt Adelman knew when he was recruited as a senior advisor to Novo Ventures in 2017 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
